Examining the biology of tuberculosis

Current Opinion in Pulmonary Medicine

Volumn 4, Issue 3, 1998, Pages 154-161

  Gonzalez Rothi, Ricardo J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

AIDS RELATED COMPLEX; DISEASE TRANSMISSION; HUMAN; LUNG TUBERCULOSIS; MICROBIOLOGY; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; RISK FACTOR; UNITED STATES;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; HUMANS; MOLECULAR BIOLOGY; PREVALENCE; RISK FACTORS; TUBERCULOSIS, PULMONARY; UNITED STATES;

EID: 0032060762     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Menzies D: Effect of treatment on contagiousness of patients with active pulmonary tuberculosis. Infect Control Hosp Epidermiol 1997, 18:582-586. An excellent critical review detailing available studies on contagiousness of tuberculosis.
2. Wilkinson D, Pillay M, Crump J, Lombard C, Davies G, Sturm AW: Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in rural africa. Trop Med Int Health 1997, 2:747-753.
3. DeLaSalmoniere YOG, Li HM, Torrea G, Bunschoten A, VanEmbden J, Gicquel B: Evaluation of spolitgotyping in a study of the transmission of Mycobacterium tuberculosis. J Clin Micro 1997, 35:2210-2214.
4. Vidal R, Miravitlles M, Cayla JA, Torella M, DeGracia J, Morell F: Increased risk of tuberculosis transmission in families with microepidemics. Bur Respir J 1997, 10:1327-1331.
5. Kritski AI, Ozorio-Marques MJ, Rabahi MF, Silva-Vieira MAM, Werneck-Barroso E, Carvalho CES, Andrade GDN, Bravo-De-Souza R, Andrade LM, Gontijo PP, Riley LW. Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 1996, 153:331-335.
6. Roy V, Weisdorf D: Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transp 1997, 19:467-470.
7. Pablos-Mendez A, Bustein J, Knirsch CA: The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Pub Health 1997, 87:574-579.
8. Murthy BVR, Pereira BJG: A 1990's perspective of hepatitis C, human immunodeficiency virus and tuberculosis infections in dialysis patients. Sem Nephrology 1997, 17:346-363.
9. Ball R, VanWey M: Tuberculosis skin test conversion among health care workers at a military medical center. Military Med 1997, 162:338-343.
10. Louther J, Rivera P, Feldman J, Villa N, DeHovitz J, Sepkowitz KA: Risk of tuberculin conversion according to occupation among health care workers at a New York City hospital. Am J Respir Crit Care Med 1997, 156-201-205.
11. MacIntyre CR, Kendig N, Kummer L, Birago S, Graham NMH: Impact of tuberculosis control measures and crowding on the evidence of tuberculosis infection in Maryland prisons. Clin Infec Dis 1997, 24:1060-1067.
12. Nolan CM, Roll L, Goldberg SV, Elarth AN: Directly observed isoniazial preventive therapy for released jail inmates. Am J Respir Crit Care Med 1997, 155:583-586. Interesting article detailing problems of compliance even within organized, directly supervised chemopreventive therapy for tuberculosis infection.
13. Zuber PLF, McKenna MT, Binkin NJ, Onorato IM, Castro KG: Long-term risk of tuberculosis among foreign-forn persons in the United States. JAMA 1997, 278:304-307. This paper describes the epidemiology of tuberculosis among foreign-born persons in the United States, whose tuberculosis case rate continues to rise.
14. Wells CD, Zuber PLF, Nolan CM, Binkin NJ, Goldberg SV: Tuberculosis prevention among foreign-born persons in Seattle-King county, Washington. Am J Respir Crit Care Med 1997, 156:573-577.
15. -1 and TNFA. Tubercle Lung Disease 1997, 78:35-45.
16. Blackwell JM, Black GF, Peacock CS, et al.: Immunogenetics of leishmanial and mycobacterial infections: the Belem family study. Phil Trans R Soc Lond B 1997, 352:1321-1345.
17. Glassroth J: Vaccines for tuberculosis: the glass remains half empty. Ann Intern Med 1997, 127:403-404.
18. Andersen P: Host responses and antigens involved in protective immunity to mycobacterium tuberculosis. Scand J Immunol 1997, 45:115-131. Excellent detailed review on the immunobiology of tuberculosis as it relates to vaccine development. Comprehensive reference.
19. Smith S, Jacobs RF, Wilson CB: Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J Pediatr 1997, 131:16-26. Well written, easy to read comprehensive review of the immune response to mycobacterial infection and of differences between children and adults.
20. Kaufmann SH, Hess J: Rational design of antituberculosis vaccines: impact of antigen display and vaccine localization. Biologicals 1997, 25:169-173.
21. Corlan E, Marica C, Macavei C, Stanford JL, Stanford CA: Immunotherapy with Mycobacterium Vaccae in the treatment of tuberculosis in Romania: 2. Chronic or relapsed disease. Respir Med 1997, 91:21-29. A good descriptive paper detailing the use of immunotherapy as adjunct to chemotherapy in patients with tuberculosis who relapsed.
22. Marsh BJ, Von Reyn CF, Arbeit RD, Morin P: Immunization of HIV-infected adults with a three-dose series of inactive Mycobacterium Vaccae. Am J Med Sci 1997, 313:377-383.
23. Cohn DL, Bustreo F, Raviglione MC: Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project Clin Inf Dis 1997, 24:S121-S130. Excellent review of the worldwide epidemiology of drug-resistant tuberculosis.
24. Moore M, Onorato IM, McCray E, Castro KG: Trends in drug-resistant tuberculosis in the clinical states, 1993-1996. JAMA 1997, 278:833-837.
25. Fuiiwara PI, Cook SV, Rutherford CM, Crawford JT, Glickman SE, Kreiswirth BN, Sachdev PS, Osahan SS, Ebrahimzadeh A, Frieden TR: A continuing survey of drug-resistant tuberculosis, New York City, April 1994. Arch Intern Med 1997, 157:531-536.
26. Sreevatsan S, Stockbauer KE, Pan X, Kreiswirth BN, Moghazeh SL, Jacobs WR, Telenti A, Musser JM: Ethambutol resistance in Mycobacterium tuberculosis: critical role of emb mutations. Antimicrob Agents Chemother 1997, 41:1677-1681.
27. Nachamkin I, Kang C, Weinstein MP: Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis. Clin Inf Dis 1997, 24:894-900.
28. Goyal M, Shaw RJ, Banerjee DK, Coker PJ, Robertson BD, Young DB: Rapid detection of multidrug-resistant tuberculosis. Eur Respir J 1997, 10:1120-1124.
29. Nash KA, Gaytan A, Inderleid CB: Detection of rifampin resistance in Mycobacterium tuberculosis by use of a rapid, simple, and specific RNA/RNA mismatch assay. J Inf Dis 1997, 176:533-536.
30. Markowitz N, Hansen NI, Hopewell PC, Glassroth J, Kvale PA, Mangura BT, Wilcosky TC, Wallace JM, Rosen MJ, Reichman LB, The Pulmonary Complications of HIV Infection Study Group: Incidence of tuberculosis in the United States among HIV-infected persons. Ann Intern Med 1997, 126:123-132. Comprehensive paper detailing the natural history of tuberculosis in HIV-infected persons in the United States.
31. Leroy V, Salmi LR, Dupon M, Sentilhes A, Texier-Maugein J, Dequae L, Dabis F, Salamon R: Progression of human immunodeficiency virus infection in patients with tuberculosis disease. Am J Epidemiol 1997, 145:293-300.
32. Alpert PL, Munsiff SS, Gourevitch MN, Greenberg B, Klein RS: A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Inf Dis 1997, 24:661-668.
33. Malkin JE, Prazuck T, Simonnet F, Yameogo M, Rochereau A, Ayeroue J, Massen D, Lafaix C: Tuberculosis and human immunodeficiency virus infection in west Burkina Faso: clinical presentation and clinical evolution, Int J Tuberc Lung Dis 1997, 1:68-74.
34. Nakata K, Rom WN, Honda Y, Condos R, Kanegasaki S, Cao Y, Weiden M: Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med 1997, 155:996-1003. Fascinating paper detailing clinically relevant interactions between HIV and tuberculosis.
35. Hecker MT, Johnson JL, Whalen CC, Nyole S, Mugerwa RD, Ellner JJ: Two-step tuberculin skin testing in HIV-infected persons in Uganda. Am J Respir Crit Care Med 1997, 155:81-86.
36. Moreno S, Miralles P, Diaz MD, Baraia J, Padilla B, Berenguer J, Alberdi JC: Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Arch Intern Med 1997, 157:1729-1734.
37. Whalen CC, Johnson JL, Okwera A, Hom DL, Huebner R, Mugyenyi P, Mugerwa RD, Ellner JJ: A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 1997, 337:801-808.
38. Gordin FM, Matts JP, Miller C, Brown LS, Hafner R, John SL, Klein M, Vaughn A, Besch CL, Perez G, Szabo S, El-Sadr W: A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. N Engl J Med 1997, 337:315-320.
39. Marsh BJ, von Reyn CF, Edwards J, Ristola MA, Bartholomew C, Brindle RJ, Gilks CF, Waddell R, Tosteson ANA, Pelz R, Sox CH, Frothingham R, Arbeit R: The risks and benefits of childhood bacille Calmette-Guerin immunization among adults with AIDS. AIDS 1997, 11:669-672.
40. Pulido F, Pena JM, Rubio R, Moreno S, Gonzalez J, Guijarro C, Costa JR, Vazquez JJ: Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients. Arch Intern Med 1997, 157:227-232.
41. Forbes BA: Critical assessment of gene amplification approaches on the diagnosis of tuberculosis. Immunol Inv 1997, 26:105-116.
42. Roth A, Schaberg T, Mauch H: Molecular diagnosis of tuberculosis: current clinical validity and future perspectives. Eur Respir J 1997, 10:1877-1891. Excellent review of attributes and potential pitfalls of nucleic acid amplification tests for diagnosing tuberculosis.
43. Lebrun L, Mathieu D, Saulnier C, Nordmann P: Limits of commercial molecular tests for diagnosis of pulmonary tuberculosis. Eur Respir J 1997, 1874-1876.
44. Smith MB, Bergmann JS, Harris SL, Woods GL: Evaluation of the Roche AMPLICOR MTB assay for the detection of Mycobacterium tuberculosis in sputum specimens from prison inmates. Diagn Microbiol Infect Dis 1997, 27:113-116.
45. Dalovisio JR, Montenegro-James S, Kemmerly SA, Genre CF, Chambers R, Greer D, Pankey GA, Failla DM, Haydel KG, Hutchinson L, Lindley MF, Nunez BM, Praba A, Eisenach KD, Cooper ES: Comparison of the amplified Mycobacterium tuberculosis (MTB) direct test, amplicor MTB PCR, and IS6110-PCR for detection of MTB in respiratory specimens. Clin Infect Dis 1996, 23:1099-1106.
46. Gamboa F, Manterola JM, Lonca J, Matas L, Vinado B, Gimenez M, Cardona PJ, Padilla E, Ausina V: Detection and identification of mycobacterium by amplification of RNA and DNA is pretreated blood and bone marrow aspirates by a single lysis method. J Clin Microbiol 1997, 35:2124-2128.
47. Tan MF, Ng WC, Chan SH, Tan WC: Comparative usefulness of PCR in the detection of Mycobacterium tuberculosis in different clinical specimens. J Med Microbiol 1997, 46:164-169.
48. Osaki M, Adachi H, Gomyo Y, Yoshida H, Ito H: Detection of mycobacterial DNA in formalin-fixed, paraffin-embedded tissue specimens by duplex polymerase chain reaction: application to histopathologic diagnosis. Mod Pathol 1997, 10:78-83.
49. Catanzaro A: New rapid tests for tuberculosis. Western J Med 1997, 166:57-58.
50. Finch D, Beaty CD: The utility of a single sputum specimen in the diagnosis of tuberculosis. Comparison between HIV-infected and non-HIV infected patients. Chest 1997, 111:1174-1179. Provocative article regarding the diagnostic value of a single sputum specimen in tuberculosis.
51. Kirsch CM, Kroe M, Azzi RL, Jensen WA, Kagawa FT, Wehner JH: The optimal number of pleural biopsy specimens for a diagnosis of tuberculosis pleurisy. Chest 1997, 112:702-706.
52. Icihyama S, Iinuma Y, Yamori S, Hasegawa Y, Shimokata K, Nakashima N: Mycobacterium growth indicator tube testing in conjunction with the AccuProbe or the AMPLICOR-PCR assay for detecting and identifying mycobacterium from sputum samples. J Clin Microbiol 1997, 35:2022-2025.
53. Casal M, Gutierrez J, Vaquero M: Comparative evaluation of the mycobacteria growth indicator tube with the BACTEC 460 TB system and Lowenstein-Jensen Medium for isolation of mycobacteria from clinical specimens. Int J Tuberc Lung Dis 1997, 1:81-84.
54. Layton MC, Henning KJ, Alexander TA, Gooding AL, Reid C, Heyman BM, Leung J, Gilmore DM, Frieden TR: Universal radiographic screening for tuberculosis inmates upon admission to jail. Am J Public Health 1997, 87:1335-1337.
55. Tuberculin skin test survey in a pediatric population with high BCG vaccination coverage. MMWR Morbid Mortal Wkly Rep 1997, 46:846-851.
56. Woeltje KF, Kilo CM, Johnson K, Primack J, Fraser VJ: Tuberculin skin testing of hospitalized patients. Infect Control Hosp Epidemiol 1997, 18:561-565.
57. Sahai J, Gallicano K, Swick L, Tailor S, Garber G, Seguin I, Oliveras L, Walker S, Rachlis A, Cameron W: Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection. Ann Intern Med 1997, 127:289-293.
58. Choudri SH, Hawken M, Gathua S, Minyiri GO, Watkins W, Sahai J, Sitar DS, Aoki FY, Long R: Pharmacokinetics of antimycobacterial drugs in patients with tuberculosis, AIDS, and diarrhea. Clin Inf Dis 1997, 25:104-111.
59. Burman WJ: The value of in vitro drug activity and pharmacokinetics in predicting the effectiveness of antimycobacterial therapy: a critical review. Am J Med Sci 1997, 313:355-363. Superb critical review on the clinical relevance (or irrelevance) of antibiotic susceptibility testing or pharmacokinetics of antituberculosis drugs.
60. Strayhorn VA, Baciewicz AM, Self TH: Update on rifampin drug interactions, III. Arch Intern Med 1997, 157:2453-2458. This paper is a good reference for the clinician on drug-drug interactions of rifampin.
61. Trebucq A: Should ethambutol be recommended for routine treatment of tuberculosis in children? A review of the literature. Int J Tuberc Lung Dis 1997, 1:12-15.